What development phase is GRANATICIN B in?

Last reviewed 2026-04-20 · How we verify

GRANATICIN B

Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	GRANATICIN B
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

GRANATICIN B CI brief — competitive landscape report
GRANATICIN B updates RSS · CI watch RSS